K-numberK260038
Device nameE3D™-C Interbody System
ApplicantEvolution Spine
Product codeOVE
Device classClass II
Decision dateFeb 4, 2026
DecisionSubstantially Equivalent
Regulation888.3080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The E3D™-C Interbody System is an intervertebral body fusion device designed for cervical spine fusion (C2-T1) in patients with degenerative disc disease, instability, trauma, deformity, spondylotic myelopathy, stenosis, or failed previous fusion. The devices are filled with autograft and/or allogeneic bone graft and come in Static (requiring supplemental fixation) and Integrated (used with screws or anchors) variants.

Technological characteristics

The implants are manufactured from titanium alloy (Ti-6Al-4V ELI) using additive Direct Metal Laser Sintering (DMLS) 3D-printing per ASTM F3001, featuring a double lattice architecture to encourage bone growth. Integrated interbodies include two screw holes and an integral cam locking mechanism. Devices are available with or without HAnano Surface®, a 20–40 nanometer hydroxyapatite surface treatment. The submission adds three new footprint sizes (20×14mm, 20×16mm, 22×19mm) to previously cleared sizes.

Test standards cited

ASTM F3001 (titanium alloy powder, additive manufacturing), ASTM F136 (titanium alloy for screws, subtractive manufacturing), ASTM F2077 (static and dynamic mechanical testing: compression, shear, torsion), ASTM F1877 (wear debris analysis), ASTM F2267 (expulsion and subsidence).

Substantial equivalence argument

The proposed implants are identical to the primary predicate (K241846) in principle of operation, indications for use, stabilization method, anatomic location, approach, product code, classification, sterilization, material, and biocompatibility. The new footprints fall within the size range of an additional predicate (Alphatec K211805). Since no new worst-case geometry is introduced, prior mechanical testing on the predicate remains applicable, demonstrating substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →